Clinical Trial Update: Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing 70% ethanol to heparin to reduce central-line infections in children with Short Bowel Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Ethanol 70% solution (ethanol)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Catheter Related Infections, Short Bowel Syndrome | Phase 2 | Status: WITHDRAWN